A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $8.8 | $252.6 | 6% |
|
| Shares Out (Mil) | 2.8 | 52.3 | 10% |
|
| Institutional Ownership | 94.6% | 92.1% | 65% |
|
| Float (Mil) | 1.6 | 40.2 | 4% |
|
| Beta | 1.68 | 0.95 | 87% |
|
| Avg Daily Volume (000s) | 11 | 455 | 17% |
|
| Price Change (52-week) |
(43.9%) | 52.9% | 18% |
|
| Growth | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (49.7%) | (9.9%) | 7% |
|
| EPS (5yr) | na | 16.0% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($1.770) | ($6.880) | ($2.910) | |
| Month Ago EPS | ($1.770) | ($6.880) | ($2.910) | |
| # Rev Up | na | 1 | 0 | |
| # Rev Down | na | 0 | 1 | |
| Three Months Ago EPS | ($2.170) | ($5.550) | ($3.150) | |
| Year/Year Chg | 0.3% | (53.5%) | (95.2%) | |
| Financials | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $38 | na |
|
| Net Income (TTM) (Mil) | ($17) | ($43) | 25% |
|
| EPS (TTM) | ($10.428) | ($1.600) | 4% |
|
| Operating Cash Flow (TTM) (Mil) | ($16) | ($31) | 16% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $5 | 41% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $5 | 19% |
|
| Enterprise Value (Q1) (Mil) | ($3) | $180 | 3% |
|
| Valuation | QNRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.98 | 2.56 | 22% |
|
| P/E | na | 19.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 63.8% | na |
|
| Net Margin | na | (67.3%) | na |
|
| ROA | (118.6%) | (49.8%) | 5% |
|
| ROE | (231.2%) | (55.5%) | 4% |
|
| Liabilities to Assets | 44.1% | 30.3% | 35% |
|
| F-Score | 3 | 3 | 19% |
|
Quoin Pharmaceuticals, Ltd. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
